Effect of technique of surfactant administration (MIST vs. InSurE) on morbidity and mortality profile of preterm neonates treated for RDS: a randomized control trial

Jeevan G. M.; Mohammed Asif; Shivprasad Talikoti; Ritika Kachhwaha

doi:10.18203/2349-3291.ijcp20232879

Authors

Jeevan G. M. Department of Pediatrics, R. N. T. Medical College, Udaipur, Rajasthan, India
Mohammed Asif Department of Pediatrics, R. N. T. Medical College, Udaipur, Rajasthan, India
Shivprasad Talikoti Department of Pediatrics, R. N. T. Medical College, Udaipur, Rajasthan, India
Ritika Kachhwaha Department of Pediatrics, R. N. T. Medical College, Udaipur, Rajasthan, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20232879

Keywords:

RDS, MIST, InSurE

Abstract

Background: Neonatal respiratory distress syndrome is a disease affecting preterm neonates caused by insufficient pulmonary surfactant in alveoli. The reported case fatality rate is 57 to 89% in low- and middle-income countries. As there is very scanty data regarding the studies on MIST technique in India, we have generated data in our institution to compare the morbidity and mortality profile in preterm babies with RDS treated with MIST and InSurE technique. Objective was to evaluate effect of technique of surfactant administration (MIST vs. InSurE) on morbidity and mortality profile of preterm neonates treated for RDS.

Methods: A Randomised controlled trial, was done on preterm neonates <34 weeks of gestation with RDS admitted in NICU between January 2020 to January 2021 who required surfactant administration. All the neonates who were fulfilling inclusion criteria after taking informed consent were randomized by colour coded chits and allotted into two groups namely Group A (MIST) & Group B (Conventional- InSurE technique).

Results: A total of 100 newborns with RDS were included in the study. Among them 50 were treated with MIST and 50 with InSurE. In the present study, there is no statistically significant differences in morbity among both the study groups but there is a statistically significant difference in the incidence of mortality between two groups that is more among InSurE group.

Conclusions: MIST technique is having similar morbidity profile in comparison to InSurE technique, but mortality rate is less in MIST than InSurE group.

Metrics

Metrics Loading ...

References

Kumar A, Bhat BV. Epidemiology Of Respiratory Distress Of Newborns. Indian J Pediatr. 1996;63(1): 93-8.

Hillman NH, Kallapur SG, Pillow JJ. Airway Injury From Initiating Ventilation In Preterm Sheep. Pediatrics Res. 2010;67:60-5.

Pinar H, Makarova N, Rubin LP, Singer DB. Pathology of the lung in surfactant treated neonates. Pediatr Pathol. 1994;14(4):627-36.

Fanos V, Pintus MC, Lussu M, Artzori L, Stronati M, Guimaraes H, et al. Urinary metabolomics of bronchopulmonary dysplasia (BPD): preliminary data at birth suggest it is congenital. J Mater Fetal Neonatol Med. 2014.

Fanos V. Cells, the tree, medicines and the tailor. Curr Pharm Des. 2012;18:2995-6.

Shaw GM, O’Brodovich HM. Progress in understanding the genetics of bronchopulmonary dysplasia. Semin Perinatol. 2013;37:85-93.

Herriges M, Morrisey EE. Lung Development: Orchestrating The Generation And Regeneration Of A Complex Organ. Development. 2014;141:502-13.

Fantz CR, Powell C, Karon B. Assessment Of The Diagnostic Accuracy Of The Tdx-FLM II To Predict Fetal Lung Maturity. Clin Chem. 2002;48:761-5.

Robertson PA, Sniderman SH, Laros RK. Neonatal Morbidity According To Gestational Age And Birth Weight From Five Tertiary Care Centers In The United States, 1983 through 1986. Am J Obstet Gynecol. 1992;166:1629-41.

Copper RL, Goldenberg RL, Creasy RK. A Multicenter Study Of Preterm Birth Weight And Gestational Age-Specific Neonatal Mortality. Am J Obstet Gynecol. 1993;168:78-84.

Guttentag S. Respiratory distress syndrome. In: Manual of Neonatal Care, Eds. Eichenwald EC, Hansen AR, Martin CR, Stark AR, 8th ed., USA: Mcgraw Hill; 2020:448-57.

Brew N, Hooper SB, Allison BJ. Injury And Repair In The Very Immature Lung Following Brief Mechanical Ventilation. Am J Physiology Lung Cell Mol Physiol. 2011;301:L917-26.

Eichenwald EC, Hansen AR, Martin CR. Respiratory distress syndrome. Cloherty and Stark’s manual of neonatal care. 8th ed. London: Taylor and Francis; 2018:436-45.

Björklund LJ, Ingimarsson J, Curstedt T. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res. 1997;42:348-55.

Schmölzer GM, Te Pas AB, Davis PG. Reducing lung injury during neonatal resuscitation of preterm infants. J Pediatr. 2008;153:741-5.

Attar MA, Donn SM. Mechanisms of ventilator-induced lung injury in premature infants. Semin Neonatol. 2002;7:353-60.

Herting E. Less invasive surfactant administration (LISA) ways to deliver surfactant in spontaneously breathing infants. Early Hum Dev. 2013;89(11):875-80.

Göpel W, Kribs A, Ziegler A. German Neonatal Network. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet. 2011;378(9803):1627-34.

Schmölzer GM, Agarwal M, Kamlin CO, Davis PG. Supraglottic airway devices during neonatal resuscitation: an historical perspective, systematic review and meta-analysis of available clinical trials. Resuscitation. 2013;84(6):722-30.

Kribs A. How best to administer surfactant to VLBW infants? Arch Dis Child Fetal Neonatal Ed. 2011;96(4): F238-40.

Mehler K, Grimme J, Abele J, Huenseler C, Roth B, Kribs A. Outcome of extremely low gestational age newborns after introduction of a revised protocol to assist preterm infants in their transition to extrauterine life. Acta Paediatr. 2012;101(12):1232-9.

Abdel-Latif ME, Osborn DA. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database Syst Rev. 2011;(7):CD008309.

Abdel-Latif ME, Osborn DA. Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database Syst Rev. 2012;(10): CD008310.

Abdel-Latif ME, Osborn DA. Pharyngeal instillation of surfactant before the ﬁrst breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome. Cochrane Database Syst Rev. 2011;(3):CD008311

Abdel-Latif ME, Osborn DA, Challis D. Intraamniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns. Cochrane Database Syst Rev. 2010;(1):CD007916

Dargaville PA. Innovation in surfactant therapy I: surfactant lavage and surfactant administration by ﬂuid bolus using minimally invasive techniques. Neonatology. 2012;101(4):326-36

Pillow JJ, Minocchieri S. Innovation in surfactant therapy II: surfactant administration by aerosolization. Neonatology. 2012;101(4):337–344

Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U: Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics. 2013; 131:e502-9.

Kribs A, Roll C, Göpel W. NINSAPP Trial Investigators. Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial. JAMA Pediatr. 2015;169: 723-30.

Pfister RH, Soll RF. Initial respiratory support of preterm infants: the role of CPAP, the InSurE method, and noninvasive ventilation. Clin Perinatol. 2012; 39(3):459-81.

Polin RA, Carlo WA. Committee on Fetus and Newborn; American Academy of Pediatrics. Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatr. 2014; 133(1):156-63.

Bao Y, Zhang G, Wu M, Ma L, Zhu J. A pilot study of less invasive surfactant administration in very preterm infants in a Chinese tertiary center. BMC Pediatr. 2015;15:21.

Tomar RPS, Ghuliani R, Yadav D. Effect of surfactant therapy using an orogastric tube for tracheal catheterization in preterm newborns with respiratory distress. Pediatric Rev. Int J Pediatr Rev. 2016;3(10): 738-44.

Choupani R, Mashayekhy G, Hmidi M, Kheiri S, Khalili DM. A Comparative Study of the Efficacy of Surfactant Administration through a Thin Intratracheal Catheter and its Administration via an Endotracheal Tube in Neonatal Respiratory Distress Syndrome. Iran J Neonatol. 2018;9(4):33-40.